D1
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
About D1
D1 is recorded as Analyst at Leerink Partners. D1 has spoken on 1 investor event across 1 company, most recently for Revolution Medicines, Inc. on May 31, 2026. The companies whose calls D1 spoke on are classified in the Healthcare sector.
D1 on recent calls
“Just two small questions on the non-G12x population. Can you provide more color on why these patients seem to derive an OIS benefit but not a PFS benefit from their exonresif?”
Affiliation history
-
Leerink Partners
Analyst
Transcript header (unverified)
Current